Abstract
Topical application of 5-fluorouracil (5-FU) is one of the most effective clinical strategies available to treat actinic keratosis (AK). During treatment, an apparent toxic skin reaction occurs before dermal quiescence ensues. We report a case of a typical flare of AK in a woman treated with capecitabine for advanced breast cancer.
Get full access to this article
View all access options for this article.
References
1.
Unis ME.
Short-term intensive 5-fluorouracil treatment of actinic keratoses . Dermatol Surg
1995 ; 21 : 162 -163 .
2.
Belisario JC.
Topical cytotoxic therapy of solar keratoses with 5-fluorouracil . Med J Aust
1969 ; 2 : 113 -640 .
3.
Callen JP
,
Bickers DR
,
Moy RL.
Actinic keratoses . JAm Acad Dermatol
1997 ; 36 : 650 -653 .
4.
Suchniak JM
,
Baer S
,
Goldberg LH.
High rate of malignant transformation in hyperkeratotic actinic keratoses . JAm Acad Dermatol
1997 ; 37 : 392 -394 .
5.
Lewis G
,
Lewis MD
,
Robinson-Bostom L
,
et al.
Inflammation of actinic keratoses during capecitabine therapy . Arch Dermatol
2004 ; 140 : 367 -368 .